Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy.
Tafelmeier M, Baessler A, Wagner S, Unsoeld B, Preveden A, Barlocco F, Tomberli A, Popovic D, Brennan P, MacGowan GA, Ristic A, Velicki L, Olivotto I, Jakovljevic DG, Maier LS.
Tafelmeier M, et al. Among authors: popovic d.
Clin Cardiol. 2020 May;43(5):430-440. doi: 10.1002/clc.23346. Epub 2020 Mar 3.
Clin Cardiol. 2020.
PMID: 32125709
Free PMC article.